Joseph M. Patti, Chief Scientific Officer at INHIBITEX, INC. (INHX), sold 209,596 shares at $8.00 ($1.6M) on 2011-11-04, disclosed to the SEC on 2011-11-08.
Scheduled sale ($1.6M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.79 | 174,596 | $1.4M | 82.9% |
| 2 | $8.00 | 35,000 | $280K | 17.1% |
| Total | $7.83 avg | 209,596 | $1.6M | 100% |
| Filing → |
| BOTA | BUY | 2014-06-30 | $14K | — | Filing → |
| BOTA | BUY | 2014-06-12 | $38K | — | Filing → |
| INHX | BUY | 2008-11-17 | $4K | — | Filing → |